New Zealand markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
32.49+0.43 (+1.34%)
At close: 04:00PM EDT
32.49 0.00 (0.00%)
After hours: 04:09PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
118,023
106,140
101,418
112,512
106,011
-
Depreciation & amortisation
1,682
2,362
3,446
3,476
2,237
-
Deferred income taxes
-29,929
-29,493
-33,905
4,346
14,089
-
Stock-based compensation
51,048
48,940
42,442
42,931
33,539
-
Change in working capital
-5,502
8,218
5,539
-466
-5,357
-
Accounts receivable
-28,961
-10,066
-3,432
-1,427
-6,270
-
Inventory
1,690
1,265
1,199
3,444
-3,514
-
Accounts payable
1,566
5,778
4,757
-3,597
3,161
-
Other working capital
124,699
126,900
119,910
167,423
150,732
-
Other non-cash items
-
-
1,383
10
1,451
-1,738
Net cash provided by operating activities
124,838
127,039
120,323
167,892
151,970
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-139
-413
-469
-1,238
-
Purchases of investments
-406,624
-328,748
-355,066
-312,805
-420,114
-
Sales/maturities of investments
281,180
419,793
241,152
449,400
302,089
-
Net cash used for investing activities
-125,583
90,906
-114,327
136,126
-119,263
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
0
Common stock repurchased
-
-145,428
0
-295,985
-9,945
-
Other financing activities
-9,634
-9,106
-21,665
-22,835
-1,067
-
Net cash used provided by (used for) financing activities
-149,447
-148,723
-17,284
-302,591
12,214
-
Net change in cash
-150,192
69,222
-11,288
1,427
44,921
-
Cash at beginning of period
299,942
66,329
77,617
76,190
31,269
-
Cash at end of period
149,750
135,551
66,329
77,617
76,190
-
Free cash flow
Operating cash flow
124,838
127,039
120,323
167,892
151,970
-
Capital expenditure
-
-139
-413
-469
-1,238
-
Free cash flow
124,699
126,900
119,910
167,423
150,732
-